Trade names from 'solution' to 'revasil' - Electronic medicinal guide TALKDRUGS

The solution for peritoneal dialysis with glucose is 1.36%, 2.27%, 3.86% by 1000. 1500, 2000. 2500. 3000. 3500, 4000, 4500, 5000. 5500. 6000
Solution for peritoneal dialysis with glucose, 1.36%, 2.27%, 3.86% by 1000. 1500. 2000. 2500. 3000. 3500. 4000, 4500, 5000. 5500. 6000
Solution for infusion. 500 ml of solution in a bottle of low-density polyethylene, with a built-in holder for the dropper, labeled
Hemofarm AD Serbia
Solution for infusions of 200, 400 ml in glass bottles for blood, transfusion and infusion. Each bottle together with the instructions for
By 250 or 500 ml into polymeric containers for infusion solutions of multilayer film based on polypropylene. Containers, 40 pieces each.

Solution for infusion.

Hemofarm AD Serbia
A solution of the hemoconservation of CFG in an amount of 63 ml in a polymer container made of polyvinyl chloride (blood bag) and a solution of the hemoconservate
Coated tablets, 2 mg.
Tablets coated with a coat of 2 mg. For 10 or 20 tablets per contour cell packaging made of polyvinylchloride film and foil
Lyophilizate for solution preparation for intramuscular and subcutaneous administration 1 million ME, 3 million ME, 5 million ME, 6 million ME, 9 million ME, 18 million
Lyophilizate for solution preparation for intramuscular and subcutaneous administration 1 million ME, 3 million ME, 5 million ME, 6 million ME, 9 million ME, 18 million
Solution for infusion 1.5% in bottles of 100, 200 or 400 ml or in polymer containers of 250 or 500 ml. Each bottle with
Concentrate for the preparation of a solution for infusions of 3.5 mg / 3.5 ml.

Novartis Pharma AG Switzerland
Capsules 150 mg, 200 mg, 300 mg.
Capsules 150 mg, 200 mg.
Liofilizate for solution for injection and topical application for 0.5 million ME or 1 million ME, or 3 million ME, or 5 million ME.
Liofilizate for the preparation of a suspension for oral administration, 250,000 ME or 500,000 ME, or 1 million ME.
Liofilizate for the preparation of a suspension for oral administration, 250,000 ME or 500,000 ME, or 1 million ME.
Capsules, 500 000 ME.

Tablets, film-coated, 100 mg. 10 tablets per blister of aluminum foil. For 3 blisters together with the instruction for
Capsules 200 mg.

Solution for intramuscular and subcutaneous administration, 150 IU / ml.

The solution for subcutaneous administration is 22 μg / 0.5 ml, 44 μg / 0.5 ml.
Merck Serono S.A. Switzerland
injection for 2 ml or 5 ml in ampoule ampoules. By 5 or 10 ampoules in a pallet of high-density polyethylene.
10 tablets per strip.
Spray for external use 2%.